Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

August 31, 2017

Conditions
Ovarian Cancer
Interventions
DEVICE

Functional Imaging previous the second course

Functional Imaging before and after 1 cycle of chemotherapy treatment, in the previous 4 days before the second course: PET1 and MRI1

DEVICE

Functional Imaging previous the surgery

Functional Imaging after 4 cycles of chemotherapy treatment, in the 3 weeks after the chemotherapy, before the interval surgery: PET4 and MRI4 The RECIST evaluation will be done, usually, by scanner to 4 courses of chemotherapy before the surgery interval

Trial Locations (1)

33076

Institut Bergonié, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Ligue contre le cancer, France

OTHER

lead

Institut Bergonié

OTHER